Management of Muscle Relaxants in Chronic Kidney Disease

Introduction to CKD Management

• The Kidney International guideline recommends blood pressure control with a target SBP <120 mmHg when tolerated, as part of the overall CKD management plan 1
• The Kidney International guideline suggests the use of RAS inhibitors (ACEi or ARB) in patients with albuminuria, as part of the overall CKD management plan 1
• The Kidney International guideline recommends sodium restriction to less than 2g/day, as part of the overall CKD management plan 1
• The Annals of Internal Medicine guideline recommends physical activity of at least 150 minutes/week of moderate-intensity exercise, as part of the overall CKD management plan 2

Muscle Relaxant Selection and Dosing

• No cited facts are available for this section, as all relevant information was marked to be ignored.